폐암 환자에서의 폐엽절제술 전후의 혈청 Alpha 1-Proteinase Inhibitor의 변화

Pre- and Postoperative Changes of Serum Levels of Slpha 1-proteinase Inhibitor in Patients with Bronchogenic Cancer

  • 발행 : 1995.03.01

초록

Malignancy is one of the several exogenous and endogenous factors that increase serum alpha 1-PI. In fact, serum levels of alpha 1-PI were significantly elevated in the patients with the nonresectable bronchogenic cancer. the purpose of this work was to determine if the immediate postoperative change of serum alpha 1-PI level following tumor resection relates to the patient`s postoperative course. Clinical experimental study was carried out to investigate the postoperative changes of serum alpha 1-PI level following operation for 20 cases of bronchogenic cancer and 10 cases of control, nephrectomy patients Alpha 1-PI concentrations in serum was quantitated by use of radial immunodiffusion technique.The results were as follows ; Preoperative serum level of alpha 1-PI was significantly elevated in patients with bronchogenic cancers [p < 0.001 , when compared to normal control levels. Immediate postoperative serum alpha 1-PI level was significantly increased in patients with bronchogenic cancer [p < 0.05 , but slightly decreased at control groups. The peak serum level of alpha 1-PI was the postoperative three days, and then gradually decreased at the 5, 9, 14 days, but slightly elevated comparing to preoperative alpha 1-PI levels. Serum alpha 1-PI level in patients with adenocarcinoma was elevated, when compared to squamous cell carcinoma, but not significantly. According to the stages of the bronchogenic cancer, each levels of the serum alpha 1-PI were slightly different, but the whole postoperative changes were the general similarity. There were no significant difference in changes of the serum alpha 1-PI level, according to the operative procedures. As the alpha 1-PI is acute reactant, that it was required at the reoperative state of the bronchogenic cancer and rapid response, consumption or requirement were occurred, postoperatively. Therefore, alpha 1-PI can be perioperative indicator for the evaluation of the bronchogenic cancer.

키워드

참고문헌

  1. Cancer v.34 Elevated Alpha I-antitrypsin serum levels in lung cancer patients Harris,C.C.;Primack,A.;Cohen,M.H.
  2. Indian J Pathol Microbiol v.30 Alpha-I-antitrypsin in lung diseases Mohan,S.R.;Somayajulu,G.L.;Agarwal,J.P.
  3. Z-Erkr-Atmungsorgane v.161 no.3 Immunohistochemical findings in intrathoracic tumors. I. Demonstration of alpha I-antitrypsin in tumor tissue Eckert,H.(et al.)
  4. Tumor Biology v.9 no.1 Biological changes in serum antiproteases as related to tumor progression Millan,J.;Senra,A.;Lorenzo,A.;Romero,J.;Rodrguez,P.;Gallurt,P.
  5. Method of biochemical analysis v.2 Determination of serum gluco protein Winzler,R.J.
  6. Biochem Biophys Acta v.516 Glycopeptide changes and malignant transformation a possible role for carbohydrate in malignant behavior Warren,L.
  7. Science v.206 Cigarette Smoking induces funtional antiprotease deficiency in the lower respiratory tract of humans James,E.G.;Gerald,A.F.
  8. Eur J Rep Dis v.62 Historical examination for E-gene alpha I-antitrypsin deficiency in small cell anaplastic carcinoma of the lung Sehested,M.;Hirsch,F.R.;Hou-Jensen,K.;Hansen,H.H.
  9. Clin Chim Acta v.31 The Alpha I-antitrypsin and macroglobulin content and the protease inhibiting capacity of normal and pathological sera Miesch,F.;Bieth,J.
  10. Am Rev Resp Dis v.132 Elastase and emphysema;Current assessment of the proteinase-antiprotease, hypothesis Janoff,A.
  11. Am Rev Resp Dis v.141 The antielastase screen of the lower respiratory tract of alpha I-proteinase inhibitor-sufficient patients with emphysema or pneumothorax Gas,A.;Dietemann-MoLard,A.;Pelletier,A.;Pauli,G.;Bieth,J.G.
  12. J Clin Invest v.66 Potential mediators of inflammation Carp,H.;Janoff,A.